Impact of Appropriate Pharmaceutical Therapy for Chronic Conditions on Direct Medical Costs and Workplace Productivity: A Review of the Literature

Neil I. Goldfarb, Christine Weston, Christine W. Hartmann, Mirko Sikirica, Albert Crawford, Hope He, Jamie Howell, Vittorio Maio, Janice Clarke, Bhaskar Nuthulaganti, Nicole Cobb

Research output: Contribution to journalArticle

Abstract

This paper presents the findings of a literature review investigating the economic impact of appropriate pharmaceutical therapy in treating four prevalent chronic conditions-asthma, diabetes, heart failure, and migraine. The goal of the review was to identify high-quality studies examining the extent to which appropriate pharmaceutical therapy impacts overall medical expenditure (direct costs) and workplace productivity (indirect costs). The working hypothesis in conducting the review was that the costs of pharmaceuticals for the selected chronic conditions are offset by savings in direct and indirect costs in other areas. The literature provides evidence that appropriate drug therapy improves the health status and quality of life of individuals with chronic illnesses while reducing costs associated with utilization of emergency room, inpatient, and other medical services. A growing body of evidence also suggests that workers whose chronic conditions are effectively controlled with medications are more productive. For employers, the evidence translates into potential direct and indirect cost savings. The findings also confirm the importance of pharmaceutical management as a corner-stone of disease management.

Original languageEnglish (US)
Pages (from-to)61-75
Number of pages15
JournalDisease Management
Volume7
Issue number1
DOIs
StatePublished - Mar 2004
Externally publishedYes

Fingerprint

Workplace
Costs and Cost Analysis
Pharmaceutical Preparations
Therapeutics
Cost Savings
Disease Management
Health Expenditures
Migraine Disorders
Health Status
Hospital Emergency Service
Inpatients
Chronic Disease
Asthma
Heart Failure
Economics
Quality of Life
Drug Therapy

ASJC Scopus subject areas

  • Health Policy

Cite this

Impact of Appropriate Pharmaceutical Therapy for Chronic Conditions on Direct Medical Costs and Workplace Productivity : A Review of the Literature. / Goldfarb, Neil I.; Weston, Christine; Hartmann, Christine W.; Sikirica, Mirko; Crawford, Albert; He, Hope; Howell, Jamie; Maio, Vittorio; Clarke, Janice; Nuthulaganti, Bhaskar; Cobb, Nicole.

In: Disease Management, Vol. 7, No. 1, 03.2004, p. 61-75.

Research output: Contribution to journalArticle

Goldfarb, NI, Weston, C, Hartmann, CW, Sikirica, M, Crawford, A, He, H, Howell, J, Maio, V, Clarke, J, Nuthulaganti, B & Cobb, N 2004, 'Impact of Appropriate Pharmaceutical Therapy for Chronic Conditions on Direct Medical Costs and Workplace Productivity: A Review of the Literature', Disease Management, vol. 7, no. 1, pp. 61-75. https://doi.org/10.1089/109350704322919005
Goldfarb, Neil I. ; Weston, Christine ; Hartmann, Christine W. ; Sikirica, Mirko ; Crawford, Albert ; He, Hope ; Howell, Jamie ; Maio, Vittorio ; Clarke, Janice ; Nuthulaganti, Bhaskar ; Cobb, Nicole. / Impact of Appropriate Pharmaceutical Therapy for Chronic Conditions on Direct Medical Costs and Workplace Productivity : A Review of the Literature. In: Disease Management. 2004 ; Vol. 7, No. 1. pp. 61-75.
@article{42aefe474a884d5fb525166156c8c2a5,
title = "Impact of Appropriate Pharmaceutical Therapy for Chronic Conditions on Direct Medical Costs and Workplace Productivity: A Review of the Literature",
abstract = "This paper presents the findings of a literature review investigating the economic impact of appropriate pharmaceutical therapy in treating four prevalent chronic conditions-asthma, diabetes, heart failure, and migraine. The goal of the review was to identify high-quality studies examining the extent to which appropriate pharmaceutical therapy impacts overall medical expenditure (direct costs) and workplace productivity (indirect costs). The working hypothesis in conducting the review was that the costs of pharmaceuticals for the selected chronic conditions are offset by savings in direct and indirect costs in other areas. The literature provides evidence that appropriate drug therapy improves the health status and quality of life of individuals with chronic illnesses while reducing costs associated with utilization of emergency room, inpatient, and other medical services. A growing body of evidence also suggests that workers whose chronic conditions are effectively controlled with medications are more productive. For employers, the evidence translates into potential direct and indirect cost savings. The findings also confirm the importance of pharmaceutical management as a corner-stone of disease management.",
author = "Goldfarb, {Neil I.} and Christine Weston and Hartmann, {Christine W.} and Mirko Sikirica and Albert Crawford and Hope He and Jamie Howell and Vittorio Maio and Janice Clarke and Bhaskar Nuthulaganti and Nicole Cobb",
year = "2004",
month = "3",
doi = "10.1089/109350704322919005",
language = "English (US)",
volume = "7",
pages = "61--75",
journal = "Population Health Management",
issn = "1942-7891",
publisher = "Mary Ann Liebert Inc.",
number = "1",

}

TY - JOUR

T1 - Impact of Appropriate Pharmaceutical Therapy for Chronic Conditions on Direct Medical Costs and Workplace Productivity

T2 - A Review of the Literature

AU - Goldfarb, Neil I.

AU - Weston, Christine

AU - Hartmann, Christine W.

AU - Sikirica, Mirko

AU - Crawford, Albert

AU - He, Hope

AU - Howell, Jamie

AU - Maio, Vittorio

AU - Clarke, Janice

AU - Nuthulaganti, Bhaskar

AU - Cobb, Nicole

PY - 2004/3

Y1 - 2004/3

N2 - This paper presents the findings of a literature review investigating the economic impact of appropriate pharmaceutical therapy in treating four prevalent chronic conditions-asthma, diabetes, heart failure, and migraine. The goal of the review was to identify high-quality studies examining the extent to which appropriate pharmaceutical therapy impacts overall medical expenditure (direct costs) and workplace productivity (indirect costs). The working hypothesis in conducting the review was that the costs of pharmaceuticals for the selected chronic conditions are offset by savings in direct and indirect costs in other areas. The literature provides evidence that appropriate drug therapy improves the health status and quality of life of individuals with chronic illnesses while reducing costs associated with utilization of emergency room, inpatient, and other medical services. A growing body of evidence also suggests that workers whose chronic conditions are effectively controlled with medications are more productive. For employers, the evidence translates into potential direct and indirect cost savings. The findings also confirm the importance of pharmaceutical management as a corner-stone of disease management.

AB - This paper presents the findings of a literature review investigating the economic impact of appropriate pharmaceutical therapy in treating four prevalent chronic conditions-asthma, diabetes, heart failure, and migraine. The goal of the review was to identify high-quality studies examining the extent to which appropriate pharmaceutical therapy impacts overall medical expenditure (direct costs) and workplace productivity (indirect costs). The working hypothesis in conducting the review was that the costs of pharmaceuticals for the selected chronic conditions are offset by savings in direct and indirect costs in other areas. The literature provides evidence that appropriate drug therapy improves the health status and quality of life of individuals with chronic illnesses while reducing costs associated with utilization of emergency room, inpatient, and other medical services. A growing body of evidence also suggests that workers whose chronic conditions are effectively controlled with medications are more productive. For employers, the evidence translates into potential direct and indirect cost savings. The findings also confirm the importance of pharmaceutical management as a corner-stone of disease management.

UR - http://www.scopus.com/inward/record.url?scp=12144288551&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=12144288551&partnerID=8YFLogxK

U2 - 10.1089/109350704322919005

DO - 10.1089/109350704322919005

M3 - Article

C2 - 15035834

AN - SCOPUS:12144288551

VL - 7

SP - 61

EP - 75

JO - Population Health Management

JF - Population Health Management

SN - 1942-7891

IS - 1

ER -